For instance, sustained drug delivery systems and smart drug delivery devices are being developed to reduce the burden of daily eye drop administration, which is often a barrier for patients[4].
according to a recall announcement published this week by the Food and Drug Administration. Alcon Laboratories voluntarily recalled a single lot of Systane Lubricant Eye Drops Ultra PF after it ...
Many pharmaceutical companies are addressing patient compliance issues by developing implants that eliminate the need for daily eye drop administration. (Image Credits: Pixabay) The glaucoma ...
Certain eye drops are being recalled over potential fungus contamination, the Food and Drug Administration announced today. Alcon Laboratories, the makers of Systane, voluntarily recalled one lot ...